229 related articles for article (PubMed ID: 21799837)
1. Differential inhibitory effects of CysLT(1) receptor antagonists on P2Y(6) receptor-mediated signaling and ion transport in human bronchial epithelia.
Lau WK; Chow AW; Au SC; Ko WH
PLoS One; 2011; 6(7):e22363. PubMed ID: 21799837
[TBL] [Abstract][Full Text] [Related]
2. Apical versus basolateral P2Y(6) receptor-mediated Cl(-) secretion in immortalized bronchial epithelia.
Wong AM; Chow AW; Au SC; Wong CC; Ko WH
Am J Respir Cell Mol Biol; 2009 Jun; 40(6):733-45. PubMed ID: 19011163
[TBL] [Abstract][Full Text] [Related]
3. Concentration-dependent noncysteinyl leukotriene type 1 receptor-mediated inhibitory activity of leukotriene receptor antagonists.
Woszczek G; Chen LY; Alsaaty S; Nagineni S; Shelhamer JH
J Immunol; 2010 Feb; 184(4):2219-25. PubMed ID: 20083671
[TBL] [Abstract][Full Text] [Related]
4. Cordyceps militaris extract stimulates Cl(-) secretion across human bronchial epithelia by both Ca(2+)(-) and cAMP-dependent pathways.
Fung JC; Yue GG; Fung KP; Ma X; Yao XQ; Ko WH
J Ethnopharmacol; 2011 Oct; 138(1):201-11. PubMed ID: 21939749
[TBL] [Abstract][Full Text] [Related]
5. G protein-coupled estrogen receptor inhibits the P2Y receptor-mediated Ca(2+) signaling pathway in human airway epithelia.
Hao Y; Chow AW; Yip WC; Li CH; Wan TF; Tong BC; Cheung KH; Chan WY; Chen Y; Cheng CH; Ko WH
Pflugers Arch; 2016 Aug; 468(8):1489-503. PubMed ID: 27271044
[TBL] [Abstract][Full Text] [Related]
6. Off-target effect of the Epac agonist 8-pCPT-2'-O-Me-cAMP on P2Y12 receptors in blood platelets.
Herfindal L; Nygaard G; Kopperud R; Krakstad C; Døskeland SO; Selheim F
Biochem Biophys Res Commun; 2013 Aug; 437(4):603-8. PubMed ID: 23850619
[TBL] [Abstract][Full Text] [Related]
7. Nobiletin Stimulates Chloride Secretion in Human Bronchial Epithelia via a cAMP/PKA-Dependent Pathway.
Hao Y; Cheung CS; Yip WC; Ko WH
Cell Physiol Biochem; 2015; 37(1):306-20. PubMed ID: 26316078
[TBL] [Abstract][Full Text] [Related]
8. CysLT1 leukotriene receptor antagonists inhibit the effects of nucleotides acting at P2Y receptors.
Mamedova L; Capra V; Accomazzo MR; Gao ZG; Ferrario S; Fumagalli M; Abbracchio MP; Rovati GE; Jacobson KA
Biochem Pharmacol; 2005 Dec; 71(1-2):115-25. PubMed ID: 16280122
[TBL] [Abstract][Full Text] [Related]
9. P2Y6 receptor-mediated proinflammatory signaling in human bronchial epithelia.
Hao Y; Liang JF; Chow AW; Cheung WT; Ko WH
PLoS One; 2014; 9(9):e106235. PubMed ID: 25243587
[TBL] [Abstract][Full Text] [Related]
10. Cysteinyl leukotriene-1 receptor activation in a human bronchial epithelial cell line leads to signal transducer and activator of transcription 1-mediated eosinophil adhesion.
Profita M; Sala A; Bonanno A; Siena L; Ferraro M; Di Giorgi R; Montalbano AM; Albano GD; Gagliardo R; Gjomarkaj M
J Pharmacol Exp Ther; 2008 Jun; 325(3):1024-30. PubMed ID: 18305014
[TBL] [Abstract][Full Text] [Related]
11. Montelukast inhibits neutrophil pro-inflammatory activity by a cyclic AMP-dependent mechanism.
Anderson R; Theron AJ; Gravett CM; Steel HC; Tintinger GR; Feldman C
Br J Pharmacol; 2009 Jan; 156(1):105-15. PubMed ID: 19068077
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of Cl- secretion via membrane-restricted Ca2+ signaling mediated by P2Y receptors in polarized epithelia.
Wong CH; Ko WH
J Biol Chem; 2002 Mar; 277(11):9016-21. PubMed ID: 11779875
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological differences among CysLT(1) receptor antagonists with respect to LTC(4) and LTD(4) in human lung parenchyma.
Ravasi S; Capra V; Panigalli T; Rovati GE; Nicosia S
Biochem Pharmacol; 2002 Apr; 63(8):1537-46. PubMed ID: 11996896
[TBL] [Abstract][Full Text] [Related]
14. Cysteinyl leukotrienes acting via granule membrane-expressed receptors elicit secretion from within cell-free human eosinophil granules.
Neves JS; Radke AL; Weller PF
J Allergy Clin Immunol; 2010 Feb; 125(2):477-82. PubMed ID: 20159258
[TBL] [Abstract][Full Text] [Related]
15. CysLT1 receptor is a target for extracellular nucleotide-induced heterologous desensitization: a possible feedback mechanism in inflammation.
Capra V; Ravasi S; Accomazzo MR; Citro S; Grimoldi M; Abbracchio MP; Rovati GE
J Cell Sci; 2005 Dec; 118(Pt 23):5625-36. PubMed ID: 16306225
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the human cysteinyl leukotriene 2 receptor.
Heise CE; O'Dowd BF; Figueroa DJ; Sawyer N; Nguyen T; Im DS; Stocco R; Bellefeuille JN; Abramovitz M; Cheng R; Williams DL; Zeng Z; Liu Q; Ma L; Clements MK; Coulombe N; Liu Y; Austin CP; George SR; O'Neill GP; Metters KM; Lynch KR; Evans JF
J Biol Chem; 2000 Sep; 275(39):30531-6. PubMed ID: 10851239
[TBL] [Abstract][Full Text] [Related]
17. Functional expression of the P2Y14 receptor in human neutrophils.
Scrivens M; Dickenson JM
Eur J Pharmacol; 2006 Aug; 543(1-3):166-73. PubMed ID: 16820147
[TBL] [Abstract][Full Text] [Related]
18. Inverse agonist activity of selected ligands of the cysteinyl-leukotriene receptor 1.
Dupré DJ; Le Gouill C; Gingras D; Rola-Pleszczynski M; Stanková J
J Pharmacol Exp Ther; 2004 Apr; 309(1):102-8. PubMed ID: 14718577
[TBL] [Abstract][Full Text] [Related]
19. Cysteinyl leukotriene receptor (CysLT) antagonists decrease pentylenetetrazol-induced seizures and blood-brain barrier dysfunction.
Lenz QF; Arroyo DS; Temp FR; Poersch AB; Masson CJ; Jesse AC; Marafiga JR; Reschke CR; Iribarren P; Mello CF
Neuroscience; 2014 Sep; 277():859-71. PubMed ID: 25090924
[TBL] [Abstract][Full Text] [Related]
20. Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor.
Sarau HM; Ames RS; Chambers J; Ellis C; Elshourbagy N; Foley JJ; Schmidt DB; Muccitelli RM; Jenkins O; Murdock PR; Herrity NC; Halsey W; Sathe G; Muir AI; Nuthulaganti P; Dytko GM; Buckley PT; Wilson S; Bergsma DJ; Hay DW
Mol Pharmacol; 1999 Sep; 56(3):657-63. PubMed ID: 10462554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]